Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006

Sexually Transmitted Diseases

Volumn 34, Issue 12, 2007, Pages 995-999

  Su, Xiaohong ^a,b   Jiang, Faxing ^a   Qimuge, ^a   Dai, Xiuqing ^a   Sun, Houhua ^a   Ye, Shunzhang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b INSTITUTE OF DERMATOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; PENICILLINASE; SPECTINOMYCIN; TETRACYCLINE;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; ENZYME SYNTHESIS; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; CHINA; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PENICILLINASE; PLASMIDS; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; TETRACYCLINE RESISTANCE;

EID: 36348946875     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3180ca8f24     Document Type: Article

References (38)

1. National Center for STD Control, CDC China. Epidemiological analysis of sexually transmitted diseases in China, 2005. STD Newsletter 2006; 2:2-12.
2. Tapsall JW. Monitoring antimicrobial resistance for public health action. Commun Dis Intell 2003; 27(suppl):S70-S74.
3. Ye S, Su X, Wang Q, et al. Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998. Sex Transm Dis 2002; 29:242-245.
4. Department of Diseases Control, Ministry of Health. Diagnostic Criteria and Management Principle of Sexually Transmitted Disease. Beijing, China: Department of Diseases Control, 2000.
5. Tapsall JW. Antimicrobial Resistance in Neisseria gonorrhoeae. WHO/CDS/CSR/DRS/ 2001.3. Geneva, Switzerland: WHO, 2001.
6. World Health Organization. Sensitivity testing of Neisseria gonorrhoeae: Methodologies for use by participants in the WHO western Pacific regional surveillance programme. In: WHO/WPR Regional Antimicrobial Surevillance Working Group Meeting Proceedings, 1992.
7. Tapsall J and Members of the National Neisseria Network of Australia. Antimicrobial testing and applications in the pathogenic Neisseria. In: Merlino J, ed. Antimicrobial Susceptibility Testing: Methods and Practices With an Australian Perspective. Sydney: Australian Society for Microbiology, 2004:175-188.
8. Turner A, Gough KR, Lemming JP. Molecular epidemiology of tetM genes in Neisseria gonorrhoeae. Sex Transm Infect 1999; 75:60-66.
9. Dillon JR, Li H, Yeung KH, et al. A PCR assay for discriminating Neisseria gonorrhoeae β-lactamase-producing plasmids. Mol Cell Probes 1999; 13:89-92.
10. Su X, Chen P, Ye S, et al. Susceptibility of isolates of Neisseria gonorrhoeae to five antimicrobial agents and distribution of auxotype. Chinese J Dermatol 1996; 29:163-165.
11. Gu W, Yang Y, Wu L, et al. Surveillence on antibiotic susceptibility of Neisseria gonorrhoeae from 1988 to 2002 in Shanghai. Chinese J Dermatol 2004; 37:323-325.
12. Marquez CM, Dillon JA, Rodriguez V, et al. Detection of a novel tetM determinant in tetracycline-resistant Neisseria gonorrhoeae from Uruguay, 1996-1999. Sex Transm Dis 2002; 29:792-797.
13. Gascoyne DM, Heritage J, Hawkey PM, et al. Molecular evolution of tetracycline-resistance plasmids carrying tetM found in Neisseria gonorrhoeae from different countries. J Antimicrob Chemother 1991; 28:173-183.
14. Greco V, Lai-king N, Catana R, et al. Molecular epidemiology of Neisseria gonorrheae isolates with plasmid-mediated tetracycline resistance in Canada: Temporal and geographical trends (1986-1997). Microb Drug Resist 2003; 9:353-360.
15. Beattie T, Moyes A, Patrizio C, et al. Subtyping of high-level plasmid-mediated tetracyline resistant Neisseria gonorrhoeae isolated in Scotland between 1992 and 1998. Int J STD AIDS 1999; 10:546-651.
16. Centers for Disease Control and Prevention. Penicillinase-producing Neisseria gonorrhoeae. MMWR Morb Mortal Wkly Rep 1976; 25:261.
17. Palmer HM, Leeming JP, Turner A. A multiplex polymerase chain reaction to differentiate β-lactamase plasmids of Neisseria gonorrhoeae. J Antimicrob Chemother 2000; 45:777-782.
18. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO western pacific region, 2004. Commun Dis Intell, 2006; 30:129-132.
19. Hsueh PR, Tseng SP, Teng LJ, et al. High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in northern Taiwan. Clin Infect Dis 2005; 40:188-192.
20. Su X, Ye S. Antibiotic Susceptibility of Neisseria gonorrhoeae to ciprofloxacin. J Clin Dermatol (Chinese) 1997; 26:356-358.
21. Wang B, Xu JS, Wang ZH, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Jiangsu province, China, with a focus on fluoroquinolone resistance. J Med Microbiol 2005; 55:1251-1255.
22. Ghanem KG, Giles JA, Zenilman JM. Fluoroquinolone-resistant Neisseria gonorrhoeae: The inevitable epidemic. Infect Dis Clin North Am 2005; 19:351-365.
23. Su X, Dai X, Ye S. Report of 8 cases of gonorrhoea with fluoroquinolones treatment failure. Chinese J STD AIDS Prev Control 2001; 20:612-613.
24. National Center for STD Control, China CDC. Guidelines for Diagnosis and Treatment of Sexually Transmitted Disease. Nanjing, China: National Center for STD Control, 2007.
25. Boslego JW, Tramont EC, Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 1987; 317:272-278.
26. Dillon JR, Ruben M, Li H, et al. Challenges in the control of gonorrhea in south America and the Caribbean: Monitoring the development of resistance to antibiotics. Sex Transm Dis 2006; 33:87-95.
27. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO western Pacific region, 2000. Commun Dis Intell 2001; 25:274-276.
28. Galimand M, Courvalin P. Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA. Antimicrob Agents Chemother 2000; 44:1365-1366.
29. Tapsall JW. Antimicrobial Resistance in Neisseria gonorrhoeae. WHO/CDS/CRS/DRS/ 2001.3. Geneva: World Health Organization, 2001:14.
30. Su X, Zhang CF, Zhang JP. Causative analysis of 3 cases of gonorrhea with spectinomycin treatment failure. Chinese J Dermatol 2003; 36:285.
31. Wang SA, Lee MVC, O'Connor N, et al. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime - Hawaii, 2001. Clin Infect Dis 2003; 37:849-852.
32. Ito M, Yasuda M, Yokoi S, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48:3185-3187.
33. Australian Gonococcal Surveillance Programme. Annual report of the Australian gonococcal surveillance programme, 2005. Commun Dis Intell 2006; 30:205-210.
34. Akasaka S, Muratani T, Yamada H, et al. Emergence of cephems and aztreonam high-resistant Neisseria gonorrhoeae that does not produce -lactamase. J Infect Chemother 2001; 7:49-50.
35. Muratani T, Akasaka S' Kobayashi Y, et al. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother 2002; 45:3603-3606.
36. Ameyama S, Onodera S, Takahata M, et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 2004; 46:3744-3749.
37. Ito M, Deguchi T, Mizutani K, et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother 2005; 49:137-143.
38. Whiley DM, Limnios A, Ray S, et al. Is the mosaic penA sequence solely responsible for decreased ceftriaxone susceptibility in Neisseria gonorrhoeae? Abstract P1.3.02. Fifteenth International Pathogenic Neisseria Conference, Cairns, September 2006:55.